Combinations comprising AMPA receptor antagonists for the treatment of schizophrenia

Details for Australian Patent Application No. 2004290890 (hide)

Owner Novartis AG

Inventors Lingenhohl, Kurt; Karolchyk, Mary Ann; Martenyi, Ferenc; Ofner, Silvio; O. Kalkman, Hans

Agent Davies Collison Cave

Pub. Number AU-B-2004290890

PCT Pub. Number WO2005/049040

Priority 0325175.8 28.10.03 GB

Filing date 27 October 2004

Wipo publication date 2 June 2005

Acceptance publication date 30 October 2008

International Classifications

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/049040 Priority application(s): WO2005/049040

30 October 2008 Application Accepted

  Published as AU-B-2004290890

26 February 2009 Standard Patent Sealed

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004290893-Compositions comprising soy products and dioic acids

2004290876-Use of perfluoropolyethers phosphates as stabilizing agents for polyphenols in cosmetic and/or dermatological compositions